- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Defensive Blue Chips
Global Pharmaceuticals & Biotech Defensive Blue Chips
UPDATED Jun 11, 2024
86 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$865.82 | 4.0% | 94.3% | US$778.9b | US$855.18 | PE127x | E27.3% | 0.6% | ||
NOVO B | kr.982.00 | 4.9% | 80.0% | kr.4.4t | kr.929.46 | PE48.8x | E13.5% | 1.0% | ||
JNJ | US$146.76 | -0.7% | -8.7% | US$354.1b | US$171.72 | PE20.7x | S4.4% | 3.4% | ||
MRK | US$131.84 | 2.4% | 19.9% | US$333.0b | US$142.68 | PE144.8x | E23.7% | 2.3% | ||
ABBV | US$167.70 | 3.4% | 21.2% | US$301.0b | US$183.04 | PE49.8x | E23.3% | 3.7% | ||
AZN | UK£123.76 | -0.2% | 5.4% | UK£191.9b | UK£136.99 | PE38.6x | E14.8% | 2.0% | ||
TMO | US$575.89 | 1.1% | 9.5% | US$222.0b | US$629.47 | PE36.4x | E10.6% | 0.3% | ||
ROG | CHF241.60 | 3.2% | -13.8% | CHF195.2b | CHF277.53 | PE16.8x | E8.8% | 4.0% | ||
NOVN | CHF94.08 | 1.5% | 4.5% | CHF192.0b | CHF98.90 | PE23.5x | E10.1% | 3.4% | ||
DHR | US$261.25 | -0.8% | 8.3% | US$196.0b | US$273.31 | PE47.6x | E13.8% | 0.4% | ||
PFE | US$28.03 | -5.0% | -30.4% | US$159.1b | US$31.92 | PS2.9x | E30.6% | 6.0% | ||
VRTX | US$481.53 | 1.4% | 40.8% | US$124.7b | US$463.42 | PE30.9x | E10.4% | n/a | ||
SAN | €89.89 | -0.4% | -4.3% | €112.4b | €108.19 | PE24.8x | E16.9% | 4.2% | ||
REGN | US$1,010.54 | 1.7% | 31.7% | US$108.1b | US$1,042.97 | PE28.3x | E12.5% | n/a | ||
CSL | AU$282.23 | -1.3% | -1.7% | AU$138.4b | AU$307.43 | PE36.5x | E14.7% | 1.3% | ||
BMY | US$43.02 | 3.0% | -33.6% | US$86.3b | US$53.19 | PS1.9x | E44.7% | 5.6% | ||
GSK | UK£16.15 | 0% | 18.2% | UK£65.9b | UK£20.36 | PE14.7x | E12.3% | 3.6% | ||
ZTS | US$178.54 | 3.9% | 7.5% | US$81.6b | US$211.20 | PE34.1x | E8.7% | 1.0% | ||
GILD | US$64.89 | 1.1% | -17.3% | US$81.3b | US$82.70 | PE166.7x | E36.2% | 4.7% | ||
MRK | €171.80 | 3.3% | 2.0% | €74.7b | €186.06 | PE27.4x | E11.3% | 1.3% | ||
4568 | JP¥5,626.00 | 0.9% | 12.5% | JP¥11.0t | JP¥6,010.00 | PE53.6x | E20.4% | 1.1% | ||
MRNA | US$148.39 | 2.1% | 15.9% | US$56.9b | US$143.95 | PS11x | E67.1% | n/a | ||
4519 | JP¥4,966.00 | 3.2% | 19.3% | JP¥8.2t | JP¥5,932.14 | PE25x | E5.3% | 1.7% | ||
SUNPHARMA | ₹1,499.75 | 4.9% | 51.8% | ₹3.6t | ₹1,615.54 | PE37.6x | E13.8% | 0.9% |